{"id":6847,"date":"2023-02-01T09:48:00","date_gmt":"2023-02-01T04:48:00","guid":{"rendered":"https:\/\/www.serenepharma.com\/?p=6847"},"modified":"2023-02-08T09:50:54","modified_gmt":"2023-02-08T04:50:54","slug":"ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari","status":"publish","type":"post","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/","title":{"rendered":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari"},"content":{"rendered":"\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098<\/p><\/blockquote>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><a href=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite.png\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite-1024x587.png\" alt=\"\" class=\"wp-image-6806\" width=\"418\" height=\"239\" srcset=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite-1024x587.png 1024w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite-300x172.png 300w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite-768x440.png 768w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite-1536x880.png 1536w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite-600x344.png 600w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite.png 1920w\" sizes=\"(max-width: 418px) 100vw, 418px\" \/><\/a><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik &#8211; venoz tromboemboliya, rejadan tashqari operatsiyalar,kasalxonada yotish kunini uzayishi va o\u2019lim ko\u2019rsatkichiga olib keluvchi mustaqil omil hisoblanadi. Ichakning yallig\u2019lanish kasalliklari bor bo\u2019lgan bemorlarda oziqlantirish yetishmovchiligi va u bilan bog\u2019liq asorat va xavflarni keng tarqalganligi tufayli bunday kasalliklarni erta aniqlash muhim ahamiyatga ega. Ichak yallig\u2019lanish kasalliklarida tashhis qo\u2019yilayotgan va tekshiruv o\u2019tkazilayotgan vaqtda to\u2019liq oziqlantirmaslik omillariga e\u2019tibor berish va oziqlanish yetishmovchiligining birlamchi va ikkilamchi profilaktikasini o\u2019tkazish kerak. Oziqlantirish yetishmovchiligi havfini skrining qilishning eng keng tarqalgan va amalda qo\u2019llaniladigan usullaridan biri bu &#8211; tana vazni indeksini aniqlash, qisqa vaqt ichida vazn yo\u2019qotish va oziq moddalarning yetarli darajada iste\u2019mol qilmaslikni tekshirilishini o\u2019z ichiga olgan Universal Oziqlantirish Yetishmovchiligini tekshiruvchi vositasi (MUST)dan foydalandik. Undan tashqari boshqa tekshiruv vositalari kasalxonaga yotkazilgan bemorlarda qo\u2019llaniladi, bulardan: to\u2019liq oziqlantirmaslikni tekshiruv vositasi ( MST), geriatrik bemorlar uchun qisqa oziqlanishni baholash (MNA\u2013SF), og\u2019ir ahvoldagi bemorlar uchun oziqlantirish havfini tekshiruvi (NRS-2002) mavjud, va bu tekshiruv parametrlari to\u2019liq oziqlanmaslik klassifikatsiyasini baholashuchun raqamli ballni berishda yordam beradi. Ichakning yallig\u2019lanishi kasalligi bilan og\u2019rigan bemorlarda oziqlanish statusini buzilishining qo\u2019shimcha sabablariga: kasallikning kechishi belgilari, mal\u044cabsorbtsiya, ichaklarda oziq moddalarning yo\u2019qotilishi, asosiy energiyaning ko\u2019p sarf etilishi ba\u2019zi bir dori vositalari kiradi. Undan tashqari bemorning ovqatlanishdan bosh tortishi, uzoq davom etuvchi chegaralangan parhezlar tibbiy muolaja olayotgan vaqtda ochlik hissini kuchayishiga sabab bo\u2019ladi. Shunday qilib, to\u2019liq ovqatlanmaslik va sarkopeniya ichak yallig\u2019lanish kasalliklarining remissiya bosqichida ham uchrashi mumkin. Ichak yalig\u2019lanish kasalliklariga xos bo\u2019lgan bunday oziqlanish yetishmovchiligi faktorlari yuqorida keltirilgan tekshiruv vositalarida kiritilmadi. Shuning uchun biz ichak yallig\u2019lanish kasalliklari bilan bog\u2019liq bo\u2019lgan umumiy belgilarni ovqatlanish yetishmovchiligini rivojlantiruvchi havfini aniqlashga harakat qildik.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Usullar: Tel-\u0410viv tibbiyot markazining ichak yallig\u2019lanish kasalliklari klinikasida 2020-2017 yillar davomida yiliga \u22652 ketma-ket shifokorga murojaat uchun kelgan bemorlar orasidagi holatni tekshirish bo\u2019yicha retrospektiv tadqiqot. Normal ovqatlanish holatiga ega va tashriflar orasida yetarli ovqatlanmaslik kuzatilgan bemorlar nazorat guruhlarida taqqoslandi. Batafsil ma\u2019lumotlar quyidagi tibbiy fayllardan olingan: demografik ma\u2019lumotlar, kasallikning fenotipi, xususiyati va faolligi, ovqatlanish ratsionining buzilishi va yondosh kasalliklar, kasallik tarixi va xirurgik aralashuvlar, yillik tibbiy yordam, oziq-ovqat iste\u2019moli va ovqatlanish yetishmovchiligini skrining universal vositasini baholash(MUST). Yetarli ovqatlanmaslik havf faktorini aniqlash uchun bir faktorli va ko\u2019p faktorli tahlillardan foydalanilgan. Ichak yallig\u2019lanish kasalligi uchun (IBD-MR) to\u2019liq ovqatlanmaslik havfini hisoblash maqsadida aniqlangan mustaqil havf omillari umumlashtirildi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Natijalar: Ichak yallig\u2019lanish kasalligi bilan kasallangan 1596 bemorning ma\u2019lumotlari tadqiqotning dastlabki mezonlariga javob berdi.Ulardan 59 bemorda ovqatlanish yetishmovchiligi rivojlandi va ular (n=59) holat sifatida qayd etildi va nazorat guruhi (n=59) bilan taqqoslandi. Shifokor bilan maslahatlar oralig\u2019i 6,2 \u00b1 3,0 oyni tashkil etdi, shu vaqt ichida bemorlar 5,3 \u00b1 2,3 kg tana vaznini yo\u2019qotdilar va nazorat guruhi 0,2 \u00b1 2,3 kg tana vaznini to\u2019pladilar (p &lt; 0,001). Kasallik holatlari va nazorat guruhi demografik ko\u2019rsatkichlari, kasallikning davomiyligi, kasallik fenotipi yoki kasallik tarixi bo\u2019yicha farq qilmadi. Ichak yallig\u2019lanish kasalligi bilan bog\u2019liq bo\u2019lgan oziqlanish yetishmovchiligi uchun mustaqil xavf omillari quyidagilar edi: 18,5 \u2264 BMI \u2264 22 kg \/ m2 (OR = 4.71, 95% CI 1.13\u201319.54), yillik tibbiy yordamning yuqori foydasi (OR = 5.67, 95% CI 1.02\u201331.30) va endoskopik kasallik faolligi (OR = 5.49, 95%CI 1.28-23.56). IBD\u2013MR MUST balldan qat\u2019iy nazar, ovqatlanish yetishmovchiligining rivojlanishi bilan ijobiy bog\u2019liq edi (OR = 7.39, 95% CI 2.60-20.94). Indeks tashrifi davomida aniqlangan MUST ballari past bo\u2019lgan bemorlar orasida \u22652 IBD-MR omillarini aniqlash ovqatlanish yetishmovchiligining rivojlanishi bilan chambarchas bog\u2019liq edi. (OR = 8.65, 95% CI 2.21\u201333.82, p = 0.002). (4)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Xulosa: Biz, ma\u2019lum bir kasallik uchun ovqatlanish yetishmovchiligi xavfini aniqlashga yordam beradigan ovqatlanish yetishmovchiligi skrining vositasiga ehtiyoj borligini ta\u2019kidlagan holda, IBD bilan bog\u2019liq ovqatlanish yetishmovchiligi uchun xavf omillarini aniqladik.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik &#8211;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":6806,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","inline_featured_image":false,"footnotes":""},"categories":[141],"tags":[172],"class_list":["post-6847","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gazetauz","tag-reanimatsiya"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"serene_admin\"\/>\n\t<meta name=\"google-site-verification\" content=\"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY\" \/>\n\t<meta name=\"yandex-verification\" content=\"4d7ed8a4cfca7240\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"uz_UZ\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Serene - The Leading Pharmaceutical Company in Central Asia\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene\" \/>\n\t\t<meta property=\"og:description\" content=\"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"83\" \/>\n\t\t<meta property=\"og:image:height\" content=\"80\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-02-01T04:48:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-02-08T04:50:54+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Serenepharma\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#blogposting\",\"name\":\"Ichakning yallig\\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene\",\"headline\":\"Ichakning yallig\\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari\",\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/181214161541_slide-colite.png\",\"width\":1920,\"height\":1100},\"datePublished\":\"2023-02-01T09:48:00+05:00\",\"dateModified\":\"2023-02-08T09:50:54+05:00\",\"inLanguage\":\"uz-UZ\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#webpage\"},\"articleSection\":\"Gazeta, Reanimatsiya, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"position\":2,\"name\":\"Gazeta\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#listItem\",\"name\":\"Ichakning yallig\\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#listItem\",\"position\":3,\"name\":\"Ichakning yallig\\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"telephone\":\"+998782910140\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/logo-.png\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#organizationLogo\",\"width\":286,\"height\":120},\"image\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Serenepharma\\\/\",\"https:\\\/\\\/www.instagram.com\\\/serene_group_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/\",\"name\":\"serene_admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"serene_admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#webpage\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/\",\"name\":\"Ichakning yallig\\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene\",\"description\":\"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\\\/doi\\\/10.3390\\\/nu 13114098 Ichakning yallig\\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\\u2019siri bilan bog\\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\\u2019liq oziqlantirmaslik -\",\"inLanguage\":\"uz-UZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/181214161541_slide-colite.png\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#mainImage\",\"width\":1920,\"height\":1100},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\\\/#mainImage\"},\"datePublished\":\"2023-02-01T09:48:00+05:00\",\"dateModified\":\"2023-02-08T09:50:54+05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"inLanguage\":\"uz-UZ\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene","description":"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -","canonical_url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY","yandex-verification":"4d7ed8a4cfca7240","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#blogposting","name":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene","headline":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari","author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite.png","width":1920,"height":1100},"datePublished":"2023-02-01T09:48:00+05:00","dateModified":"2023-02-08T09:50:54+05:00","inLanguage":"uz-UZ","mainEntityOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#webpage"},"isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#webpage"},"articleSection":"Gazeta, Reanimatsiya, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","position":1,"name":"Home","item":"https:\/\/www.serenepharma.com\/uz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","position":2,"name":"Gazeta","item":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#listItem","name":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#listItem","position":3,"name":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari","previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}}]},{"@type":"Organization","@id":"https:\/\/www.serenepharma.com\/uz\/#organization","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","url":"https:\/\/www.serenepharma.com\/uz\/","telephone":"+998782910140","logo":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/logo-.png","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#organizationLogo","width":286,"height":120},"image":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/Serenepharma\/","https:\/\/www.instagram.com\/serene_group_\/"]},{"@type":"Person","@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author","url":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/","name":"serene_admin","image":{"@type":"ImageObject","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g","width":96,"height":96,"caption":"serene_admin"}},{"@type":"WebPage","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#webpage","url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/","name":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene","description":"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -","inLanguage":"uz-UZ","isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/#website"},"breadcrumb":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#breadcrumblist"},"author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"creator":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/181214161541_slide-colite.png","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#mainImage","width":1920,"height":1100},"primaryImageOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/#mainImage"},"datePublished":"2023-02-01T09:48:00+05:00","dateModified":"2023-02-08T09:50:54+05:00"},{"@type":"WebSite","@id":"https:\/\/www.serenepharma.com\/uz\/#website","url":"https:\/\/www.serenepharma.com\/uz\/","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","inLanguage":"uz-UZ","publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"}}]},"og:locale":"uz_UZ","og:site_name":"Serene - The Leading Pharmaceutical Company in Central Asia","og:type":"article","og:title":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene","og:description":"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -","og:url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/","og:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:secure_url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:width":83,"og:image:height":80,"article:published_time":"2023-02-01T04:48:00+00:00","article:modified_time":"2023-02-08T04:50:54+00:00","article:publisher":"https:\/\/www.facebook.com\/Serenepharma\/","twitter:card":"summary","twitter:title":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari - Serene","twitter:description":"Ilova: Eynav.L va boshqalar (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari, Oziq moddalar 2021,13,40986. https:\/doi\/10.3390\/nu 13114098 Ichakning yallig\u2019lanish kasalliklari (IYaK)da oziqlanishning yetishmovchiligini tarqalishi IYaKning turiga, kasallikning klinik kechishi va faolligiga qarab 6,1%dan 69,7%gacha yetadi. To\u2019liq ovqatlanmaslik va sarkopeniya yomon klinik natijalar, gospitalizatsiya, davolashning hayot sifatiga ta\u2019siri bilan bog\u2019liqdir. Gospitalizatsiya qilingan bemorlar orasida to\u2019liq oziqlantirmaslik -","twitter:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png"},"aioseo_meta_data":{"post_id":"6847","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-02-11 16:42:28","updated":"2026-02-11 16:42:28","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/\" title=\"Gazeta\">Gazeta<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tIchakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.serenepharma.com\/uz\/"},{"label":"Gazeta","link":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/"},{"label":"Ichakning yallig\u2019lanish kasalligi (IYK) bor bemorlarda oziqlantirish yetishmovchiligidagi havf omillari","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/ichakning-yalliglanish-kasalligi-iyk-bor-bemorlarda-oziqlantirish-yetishmovchiligidagi-havf-omillari\/"}],"_links":{"self":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/comments?post=6847"}],"version-history":[{"count":0,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6847\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media\/6806"}],"wp:attachment":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media?parent=6847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/categories?post=6847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/tags?post=6847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}